SCYX
SCYNEXIS INC
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$4.46
+0.22%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 34.07x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.66x
- Price / sales
- 2.31x
- Price / cash flow
- -3.33x
Enterprise value
- Enterprise value
- -$7.8M
- EV / sales
- -0.40x
- EV / EBITDA
- 0.76x
- EV / EBIT
- 0.34x
- Market cap
- $44.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026